This article was originally published in The Gray Sheet
Executive SummaryLaunches hepatitis B surface antigen enzyme immunoassay in 51 countries. The product is the first HBsAG test to incorporate color changes at each step of the testing process, Murex claims. Offered to clinical labs and blood banks, the test represents a "safety enhancement," over existing tests, the firm adds
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.